Scientists have developed a novel electrochemical delamination process to create durable, flexible giant magnetoresistive sensors with enhanced sensitivity, paving the way for advanced wearable skin technologies.
Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders | Psychedelic Invest
Tel Aviv, Israel / Vancouver, Canada, April 17, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “company”), a biotech company focused on discovery and development